Abstract：
SummaryEpistaxis is a common condition that can be associated with significant morbidity, and it places a considerable burden on our healthcare system. In China, a draft guidelines for diagnosis and treatment of epistaxis was released in 2015. In UK, a national audit of management for epistaxis was promulgated in 2016, followed by multidisciplinary consensus recommendations on the hospital management of epistaxis in 2017. Here, we compared the management of diagnosis and treatment for epistaxis between China and UK in five clinical aspects, including initial assessment, cautery, intranasal agents, antithrombotic therapy and hematological factors, as well as surgery and radiological intervention. The results demonstrate that the management recommendations in UK combined a wide-ranging review of the relevant literature with established and rigorous methods of guideline generation, while the guidelines in China is more specific on the procedures of diagnosis and treatment for epistaxis. The current discussion provides perspectives to improve the guidelines for epistaxis in China.
摘要：
SummaryEpistaxis是一种常见的疾病，可以与显著的发病率有关，这给我们的医疗系统带来了相当大的负担。在中国,2015年发布了鼻出血诊断和治疗指南草案.在英国,2016年颁布了鼻出血管理国家审计,随后于2017年就医院鼻出血管理提出了多学科共识建议.这里,我们从五个临床方面比较了中国和英国鼻出血的诊断和治疗方法，包括初步评估，烧灼,鼻内药物,抗血栓治疗和血液学因素，以及手术和放射干预。结果表明，英国的管理建议结合了相关文献的广泛审查和既定的和严格的指南生成方法，而中国的指南对鼻出血的诊断和治疗程序更为具体。当前的讨论提供了改进中国鼻出血指南的观点。
